246 related articles for article (PubMed ID: 32248662)
1. Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariates.
Van Lancker K; Vandebosch A; Vansteelandt S
Pharm Stat; 2020 Sep; 19(5):583-601. PubMed ID: 32248662
[TBL] [Abstract][Full Text] [Related]
2. Interim analysis incorporating short- and long-term binary endpoints.
Niewczas J; Kunz CU; König F
Biom J; 2019 May; 61(3):665-687. PubMed ID: 30694566
[TBL] [Abstract][Full Text] [Related]
3. A flexible futility monitoring method with time-varying conditional power boundary.
Ying Zhang ; Clarke WR
Clin Trials; 2010 Jun; 7(3):209-18. PubMed ID: 20423927
[TBL] [Abstract][Full Text] [Related]
4. Optimal futility stopping boundaries for binary endpoints.
Freitag MM; Li X; Rauch G
BMC Med Res Methodol; 2024 Mar; 24(1):80. PubMed ID: 38539108
[TBL] [Abstract][Full Text] [Related]
5. Operating characteristics of sample size re-estimation with futility stopping based on conditional power.
Lachin JM
Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019
[TBL] [Abstract][Full Text] [Related]
6. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
7. Optimal timing for an accelerated interim futility analysis incorporating real world data.
Haine LMF; Murray TA; Koopmeiners JS
Contemp Clin Trials; 2024 May; 140():107489. PubMed ID: 38461938
[TBL] [Abstract][Full Text] [Related]
8. Upstrapping to determine futility: predicting future outcomes nonparametrically from past data.
Wild JL; Ginde AA; Lindsell CJ; Kaizer AM
Trials; 2024 May; 25(1):312. PubMed ID: 38725072
[TBL] [Abstract][Full Text] [Related]
9. Choice of futility boundaries for group sequential designs with two endpoints.
Schüler S; Kieser M; Rauch G
BMC Med Res Methodol; 2017 Aug; 17(1):119. PubMed ID: 28789615
[TBL] [Abstract][Full Text] [Related]
10. When inferiority meets non-inferiority: implications for interim analyses.
Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
[TBL] [Abstract][Full Text] [Related]
11. Information time scales for interim analyses of randomized clinical trials.
Freidlin B; Othus M; Korn EL
Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947
[TBL] [Abstract][Full Text] [Related]
12. A systematic survey of randomised trials that stopped early for reasons of futility.
Walter SD; Han H; Guyatt GH; Bassler D; Bhatnagar N; Gloy V; Schandelmaier S; Briel M
BMC Med Res Methodol; 2020 Jan; 20(1):10. PubMed ID: 31948397
[TBL] [Abstract][Full Text] [Related]
13. Using short-term endpoints to improve interim decision making and trial duration in two-stage phase II trials with nested binary endpoints.
Zocholl D; Kunz CU; Rauch G
Stat Methods Med Res; 2023 Sep; 32(9):1749-1765. PubMed ID: 37489267
[TBL] [Abstract][Full Text] [Related]
14. Hybridization of conditional and predictive power for futility assessment in sequential clinical trials with time-to-event outcomes: a resampling approach.
Yi J; Fang L; Su Z
Contemp Clin Trials; 2012 Jan; 33(1):138-42. PubMed ID: 21983624
[TBL] [Abstract][Full Text] [Related]
15. Blinded continuous monitoring in clinical trials with recurrent event endpoints.
Friede T; Häring DA; Schmidli H
Pharm Stat; 2019 Jan; 18(1):54-64. PubMed ID: 30345693
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
Walter SD; Han H; Briel M; Guyatt GH
Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
[TBL] [Abstract][Full Text] [Related]
17. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
Ryan EG; Brock K; Gates S; Slade D
BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
[TBL] [Abstract][Full Text] [Related]
18. Assessment of futility in clinical trials.
Snapinn S; Chen MG; Jiang Q; Koutsoukos T
Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
[TBL] [Abstract][Full Text] [Related]
19. Evaluating futility of a binary clinical endpoint using early read-outs.
Van Lancker K; Vandebosch A; Vansteelandt S; De Ridder F
Stat Med; 2019 Dec; 38(28):5361-5375. PubMed ID: 31631357
[TBL] [Abstract][Full Text] [Related]
20. Alternative views on setting clinical trial futility criteria.
Gallo P; Mao L; Shih VH
J Biopharm Stat; 2014; 24(5):976-93. PubMed ID: 24933121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
